大禹生物
(920970)
| 流通市值：3.92亿 | | | 总市值：6.20亿 |
| 流通股本：7007.13万 | | | 总股本：1.11亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 136,198,629.41 | 71,914,063.08 | 33,740,362.7 | 167,480,613.05 |
| 营业总成本 | 157,761,377.75 | 84,319,961.11 | 38,871,433.38 | 199,734,100.78 |
| 其他经营收益 | | | | |
| 营业利润 | -37,583,305.41 | -26,549,863.14 | -17,416,890.13 | -29,702,791.94 |
| 利润总额 | -37,587,052.79 | -26,549,609.3 | -17,416,636.89 | -29,823,809.91 |
| 净利润 | -37,587,052.79 | -26,549,609.3 | -17,416,636.89 | -29,853,181.08 |
| 每股收益 | | | | |
| 其他综合收益 | 2,626,320 | -6,880 | - | - |
| 综合收益总额 | -34,960,732.79 | -26,556,489.3 | -17,416,636.89 | -29,853,181.08 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 97,750,616.99 | 103,672,941.95 | 92,911,547.35 | 89,898,484.96 |
| 非流动资产: | | | | |
| 非流动资产合计 | 356,449,676.73 | 358,424,895 | 354,339,134.89 | 345,913,491.8 |
| 资产总计 | 454,200,293.72 | 462,097,836.95 | 447,250,682.24 | 435,811,976.76 |
| 流动负债: | | | | |
| 流动负债合计 | 164,800,595.14 | 159,702,908.66 | 138,797,758.84 | 115,265,805.18 |
| 非流动负债: | | | | |
| 非流动负债合计 | 60,847,800.24 | 65,438,786.46 | 62,356,929.16 | 57,033,540.45 |
| 负债合计 | 225,648,395.38 | 225,141,695.12 | 201,154,688 | 172,299,345.63 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 228,551,898.34 | 236,956,141.83 | 246,095,994.24 | 263,512,631.13 |
| 股东权益合计 | 228,551,898.34 | 236,956,141.83 | 246,095,994.24 | 263,512,631.13 |
| 负债和股东权益合计 | 454,200,293.72 | 462,097,836.95 | 447,250,682.24 | 435,811,976.76 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 154,648,794.92 | 82,563,300.05 | 35,344,932.86 | 198,208,247.83 |
| 经营活动现金流出小计 | 170,529,405.15 | 105,380,592.15 | 53,963,038.84 | 188,026,883.49 |
| 经营活动产生的现金流量净额 | -15,880,610.23 | -22,817,292.1 | -18,618,105.98 | 10,181,364.34 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 145,000 | - | - | - |
| 投资活动现金流出小计 | 32,515,579.56 | 30,150,679.2 | 17,328,927.71 | 43,035,524.75 |
| 投资活动产生的现金流量净额 | -32,370,579.56 | -30,150,679.2 | -17,328,927.71 | -43,035,524.75 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 171,400,000 | 171,400,000 | 50,400,000 | 107,900,000 |
| 筹资活动现金流出小计 | 143,889,412.26 | 131,944,763.75 | 15,715,160.41 | 70,321,379.27 |
| 筹资活动产生的现金流量净额 | 27,510,587.74 | 39,455,236.25 | 34,684,839.59 | 37,578,620.73 |
| 汇率变动对现金及现金等价物的影响 | -34,814.99 | -19,261.26 | -5,570.36 | -4,869.48 |
| 现金及现金等价物净增加额 | -20,775,417.04 | -13,531,996.31 | -1,267,764.46 | 4,719,590.84 |
| 期末现金及现金等价物余额 | 9,619,007.54 | 16,862,428.27 | 29,126,660.12 | 30,394,424.58 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -13,531,996.31 | - | 4,719,590.84 |